Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on May 13, 2021 on account of Id-Ul-Fitr (Ramzan Id).

Realty & banking stocks, major losers
Tue, 16 Jul 01:30 pm

Due to persistent weakness in index heavy-weights Indian share markets continued to trade deep in the red in the post-noon trading session. Majority of the sectoral indices are trading in the red with realty, banking and capital goods stocks being the biggest losers. However, FMCG, oil and gas and IT stocks are among the few stocks trading in the green.

BSE-Sensex is down 244 points and NSE-Nifty is trading 86 points down. BSE Mid Cap is trading down 1.2% and BSE Small Cap index is trading down by 0.8%. The rupee is trading at 59.4 to the US dollar.

Energy stocks are trading mixed with Oil & Natural Gas Corporation (ONGC) and Bharat Petroleum Corporation Ltd (BPCL) being the biggest gainers while Jindal Drill and Mangalore Refineries & Petrochemicals Ltd (MRPL) are the biggest losers. As per a leading financial daily, Reliance Industries Ltd (RIL) is no longer interested in the gas distribution business. Reliance Gas had won bids for city gas distribution for three cities namely Rajahmundry in Andhra Pradesh, Shahdol in Madhya Pradesh and Yanam in Pondicherry in 2009 during the second round of bidding. However, as per Petroleum and Natural Gas Regulatory Board (PNGRB), RIL has said that it is no longer interested in laying pipelines in these cities. Reportedly distribution in these three cities may be put up on auction again. In February, PNGRB had issued licences for piped natural gas in six cities. RIL stock is currently trading down by 0.3%.

Domestic pharma stocks are trading mixed with Indoco Remdies and Biocon being the leading gainers and Dishman Pharma and Aurobindo Pharma being the biggest losers. Glenmark recently confirmed its Para IV challenge for drug Vimpat brand (generically known as Lacosamide tablets) in US. The company has filed an ANDA (Abbreviated New Drug Application) with Para IV for both tablets and oral solution. The drug is indicated as adjunctive therapy for the treatment for epilepsy. UCB is the innovator of the drug. Reportedly, on back of the Para IV filing, the innovator has sued Glenmark in the district court of Delaware to prevent Glenmark from early launch of drug before the patent expiry in March 2022. Annual sales of Vimpat brand in the US stand at around US$ 353 m. If Glenmark is successful in its patent challenge then it will have a fair chance of availing the 180-days exclusivity. Glenmark is trading up by 0.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Realty & banking stocks, major losers". Click here!

  

Related Views on News

RELIANCE IND. Announces Quarterly Results (2QFY21); Net Profit Down 7.1% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, RELIANCE IND. has posted a net profit of Rs 105 bn (down 7.1% YoY). Sales on the other hand came in at Rs 1,162 bn (down 23.6% YoY). Read on for a complete analysis of RELIANCE IND.'s quarterly results.

RELIANCE IND. 2019-20 Annual Report Analysis (Annual Result Update)

Aug 5, 2020 | Updated on Aug 5, 2020

Here's an analysis of the annual report of RELIANCE IND. for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of RELIANCE IND.. Also includes updates on the valuation of RELIANCE IND..

RELIANCE IND. Announces Quarterly Results (1QFY21); Net Profit Up 27.8% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, RELIANCE IND. has posted a net profit of Rs 129 bn (up 27.8% YoY). Sales on the other hand came in at Rs 912 bn (down 43.5% YoY). Read on for a complete analysis of RELIANCE IND.'s quarterly results.

RELIANCE IND. 2018-19 Annual Report Analysis (Annual Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

Here's an analysis of the annual report of RELIANCE IND. for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of RELIANCE IND.. Also includes updates on the valuation of RELIANCE IND..

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE OIL & GAS


May 12, 2021 (Close)

S&P BSE OIL & GAS 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS